Clinical Trials Logo

Congenital Abnormalities clinical trials

View clinical trials related to Congenital Abnormalities.

Filter by:

NCT ID: NCT06462989 Not yet recruiting - Clinical trials for Structural Heart Abnormality

Harnessing ECG Artificial Intelligence for Rapid Treatment and Accurate Interpretation, an Open Label Randomized Controlled Trial

HEART-AI
Start date: July 1, 2024
Phase: N/A
Study type: Interventional

The HEART-AI (Harnessing ECG Artificial Intelligence for Rapid Treatment and Accurate Interpretation) is an open-label, single-center, randomized controlled trial, that aims to deploy a platform called DeepECG at point-of-care for AI-analysis of 12-lead ECGs. The platform will be tested among healthcare professionals (medical students, residents, doctors, nurse practitioners) who read 12-lead ECGs. In the intervention group, the platform will display the ECHONeXT structural heart disease (SHD) scores in randomized patients to help doctors prioritize TTEs (Supplemental Table 2, Figure 1). Also, this platform will display the DeepECG-AI interpretation which detects problems such as ischemic conditions, arrhythmias or chamber enlargements and acts an improved alternative to commercially available ECG interpretation systems such as MUSE (Supplemental Table 1). The performance for both of these models is presented in supplemental appendix (Supplemental Table 1, Supplemental Table 2, Supplemental Figure 1). Our primary objective is to assess the impact of displaying the ECHONeXT interpretation on 12-lead ECGs, specifically focusing on the detection rates of Structural Heart Disease (SHD) on TTE among newly referred patients at MHI and on the delay between the time of the first ECG opened in the platform and the TTE evaluation among newly referred patients at MHI at high or intermediate risk of SHD, by comparing patients in the intervention (ECHONeXT prediction of SHD displayed and recommendation on the priority to assign to the TTE) arm and patients in the control (ECHONeXT prediction and recommendation hidden) arm. The main secondary objective is to evaluate the proportion of ECGs where the users agree with the DeepECG diagnosis, across all ECGs accessed by the user of the platform. By integrating an AI-analysis platform at the point of care and evaluating its impact on ECG interpretation accuracy and prioritization of incremental tests, the HEART-AI study aims to provide valuable insights into the potential of AI in improving cardiac care and patient outcomes.

NCT ID: NCT06448832 Not yet recruiting - Clinical trials for Abnormality, Congenital

Relationship of Muscular Agenesis: Thin Plantar and Palmar Long as a Biomarker of Injury and Performance Marker in the Lower Limb and Upper Limb Respectively

MA-TP-PL
Start date: September 1, 2024
Phase:
Study type: Observational

This study investigates muscle agenesis, specifically the absence of the palmaris longus and plantaris muscles, and its effects on injury risk, strength, and performance. Muscle injuries are common in sports, and the presence or absence of certain muscles can impact biomechanics and injury susceptibility. The study involves 132 subjects, divided into those with and without muscle agenesis, assessing injuries with the Nordic and CMDQ questionnaires and measuring strength with dynamometers. Results aim to clarify the controversial impact of muscle agenesis on functional disability and performance adaptation in the scientific literature.

NCT ID: NCT06440499 Not yet recruiting - Clinical trials for Kidney Congenital Anomalies

Screening of Congenital Anomalies of Kidney

Start date: July 1, 2024
Phase:
Study type: Observational

To evaluate the role of ultrasound in prenatal diagnosis of congenital anomalies of kidney and urinary system in third trimester of pregnancy. Primay outcomes: To determine incidence of congenital anomalies in kidney and urinary system in Third Timerter by ultrasound.

NCT ID: NCT06437561 Completed - Vascular Diseases Clinical Trials

Report of Ten Cases of Venous Aneurysm in Extremities

Start date: February 13, 2024
Phase:
Study type: Observational

Venous aneurysms are not common in general, but because of the inherent risk of thrombosis in aneurysms, their timely diagnosis and treatment are recommended in most of the current sources. Ten cases of venous aneurysms were diagnosed and managed in our vascular surgery department from October 2018 to January 2024. Patient information was extracted from their files retrospectively.

NCT ID: NCT06437158 Recruiting - Clinical trials for Lymphatic Malformation

Use of Bleomycin in the Sclerotherapy of Lymphatic Malformations for Pediatric Patients

Start date: March 8, 2023
Phase: Phase 2
Study type: Interventional

Bleomycin has nowadays been more and more widely used in the sclerotherapy of LMs, which has been proven to be primarily dose dependent. The investigators aim to compare the efficacy and safety of different concentrations of Bleomycin in the sclerotherapy of LMs for pediatric patients.

NCT ID: NCT06431698 Recruiting - Ear Malformation Clinical Trials

CORRECTION OF EAR DEFORMITIES IN NEWBORNS BY MODELING, COMPARISON OF TWO PROTOCOLS

MOLDEAR
Start date: July 31, 2023
Phase: N/A
Study type: Interventional

Evaluation of the non-inferiority of the custom-made device developed in the maxillofacial surgery department of Caen University Hospital compared to the device from the EarWellâ„¢ group

NCT ID: NCT06424392 Not yet recruiting - Clinical trials for Congenital Lung Malformations

Respiratory and Psychological Impact of Elective Surgery of Congenital Lung Malformations

MALFPULM2
Start date: July 2024
Phase:
Study type: Observational

The absence of surgery of Congenital lung malformations (CLMs), if it avoids a stressfull event, is accompanied by a "medicalization" of the child, which will be regularly followed up in a specialized medical and surgical environment. The persistent risk of complication, albeit low, is likely to induce over-protective parental behaviours, and to be associated with a sustained family anxiety reaction. The main objective is to test the hypothesis that the absence of surgery has a significant impact on parental anxiety, measurable at 6- 9 years of age.

NCT ID: NCT06412939 Not yet recruiting - Fractures, Bone Clinical Trials

Retrospective Study on Clinical Performance and Safety Profile of Agile Nail

Agile
Start date: June 2024
Phase:
Study type: Observational

This study aims to retrospectively collect data from routine clinical practice in order to evaluate the safety profile of the Agile intramedullary nail, used in pediatric patients according to the manufacturer Instructions For Use (IFU) in the time frame from the time of surgery until the last follow-up visit available at the hospitals.

NCT ID: NCT06410391 Recruiting - Fetal Anomaly Clinical Trials

Fetal Brain Ultrasound

Start date: June 15, 2024
Phase:
Study type: Observational

The aim of our study is to determine the range of frontal horn sizes (both upside and downside) in healthy fetuses over gestation and to determine how far FHs are from the midline . Also to determine the range of cavum septi pellucidi and Corpus callosum sizes . Also, to determine whether the maternal body mass index (BMI) affects rates of visualized and non-visualized CSP and CC.

NCT ID: NCT06407713 Recruiting - Clinical trials for Pronation Deformity of the Foot

Intrinsic Foot Muscle Training With and Without Hip Abductor Muscle Strengthening in Pronation Distortion Syndrome

Start date: May 2, 2024
Phase: N/A
Study type: Interventional

Pronation distortion syndrome is one of the most common abnormalities in the lower extremity that causes alterations in the structures of the skeletal parts of the foot. The aim of the study will be to compare the effects of intrinsic foot muscle with and without hip abductor muscle strengthening on pain and functional mobility in patients with Pronation Distortion Syndrome.